PFE earnings date and last-quarter result: P/E 18.95. Updated 2026-07-23.
Pfizer (PFE) Research Hub
Pfizer (PFE) trades on NYSE, US in the Healthcare (Drug Manufacturers - General) sector. As of 2026-10-26, shares last closed at 29.79 USD (-0.80%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 18.95, market cap 142.06B. This hub links to the full technical, earnings and options research available for PFE.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - General) |
|---|---|
| Exchange | NYSE, US |
| Last close | 29.79 USD (-0.80%) |
| 52-week range | 23.62 USD – 30.44 USD |
| Trend regime | Range |
| 14-day RSI | 74.1 (Overbought) |
| Trailing P/E | 18.95 |
| Market cap | 142.06B |
| Dividend yield | 6.93% |
Available research for PFE
Covered Call on PFE: how it works, illustrative setup around the real 29.79 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PFE: how it works, illustrative setup around the real 29.79 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PFE: how it works, illustrative setup around the real 29.79 USD price, max profit/loss, breakeven and when to use it. Educational.
PFE technical analysis: range, last 29.79 USD, RSI 74.1, 52w range 23.62 USD–30.44 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PFE in?
Pfizer (PFE) is classified under Healthcare (Drug Manufacturers - General), listed on NYSE, US.
Is PFE in an uptrend or downtrend?
As of 2026-10-26, PFE is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PFE's trailing P/E ratio?
PFE's trailing P/E is 18.95, with a market cap of 142.06B. See the earnings research page for full valuation detail.